Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

ICTV Virus Taxonomy Profile: Deltavirus.

Magnius L, Taylor J, Mason WS, Sureau C, Dény P, Norder H, Ictv Report Consortium.

J Gen Virol. 2018 Dec;99(12):1565-1566. doi: 10.1099/jgv.0.001150. Epub 2018 Oct 12.

PMID:
30311870
2.

Why, who and when to start treatment for chronic hepatitis B infection.

Dolman GE, Koffas A, Mason WS, Kennedy PT.

Curr Opin Virol. 2018 Jun;30:39-47. doi: 10.1016/j.coviro.2018.03.006. Epub 2018 Apr 11. Review.

PMID:
29655092
3.

Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks.

Kennedy PTF, Litwin S, Dolman GE, Bertoletti A, Mason WS.

Viruses. 2017 Apr 29;9(5). pii: E96. doi: 10.3390/v9050096. Review.

4.

Reply.

Kennedy PTF, Bertoletti A, Mason WS.

Gastroenterology. 2017 Apr;152(5):1246-1247. doi: 10.1053/j.gastro.2017.03.002. Epub 2017 Mar 6. No abstract available.

PMID:
28273438
5.

HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.

Mason WS, Gill US, Litwin S, Zhou Y, Peri S, Pop O, Hong ML, Naik S, Quaglia A, Bertoletti A, Kennedy PT.

Gastroenterology. 2016 Nov;151(5):986-998.e4. doi: 10.1053/j.gastro.2016.07.012. Epub 2016 Jul 22.

PMID:
27453547
6.

HBV replication, pathobiology and therapy: Unanswered questions.

Seeger C, Mason WS.

J Hepatol. 2016 Apr;64(1 Suppl):S1-S3. doi: 10.1016/j.jhep.2016.01.006.

PMID:
27084030
7.

Animal models and the molecular biology of hepadnavirus infection.

Mason WS.

Cold Spring Harb Perspect Med. 2015 Apr 1;5(4). pii: a021352. doi: 10.1101/cshperspect.a021352. Review.

8.

Molecular biology of hepatitis B virus infection.

Seeger C, Mason WS.

Virology. 2015 May;479-480:672-86. doi: 10.1016/j.virol.2015.02.031. Epub 2015 Mar 7. Review.

9.

Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.

Zeisel MB, Lucifora J, Mason WS, Sureau C, Beck J, Levrero M, Kann M, Knolle PA, Benkirane M, Durantel D, Michel ML, Autran B, Cosset FL, Strick-Marchand H, Trépo C, Kao JH, Carrat F, Lacombe K, Schinazi RF, Barré-Sinoussi F, Delfraissy JF, Zoulim F.

Gut. 2015 Aug;64(8):1314-26. doi: 10.1136/gutjnl-2014-308943. Epub 2015 Feb 10. Review.

PMID:
25670809
10.

Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection.

Tu T, Mason WS, Clouston AD, Shackel NA, McCaughan GW, Yeh MM, Schiff ER, Ruszkiewicz AR, Chen JW, Harley HA, Stroeher UH, Jilbert AR.

J Viral Hepat. 2015 Sep;22(9):737-53. doi: 10.1111/jvh.12380. Epub 2015 Jan 26.

PMID:
25619231
11.

Virology. Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA".

Chisari FV, Mason WS, Seeger C.

Science. 2014 Jun 13;344(6189):1237. doi: 10.1126/science.1254082.

12.

Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver.

Reaiche-Miller GY, Thorpe M, Low HC, Qiao Q, Scougall CA, Mason WS, Litwin S, Jilbert AR.

Virology. 2013 Nov;446(1-2):357-64. doi: 10.1016/j.virol.2013.08.014. Epub 2013 Sep 13.

13.

Sodium-dependent taurocholic cotransporting polypeptide: a candidate receptor for human hepatitis B virus.

Seeger C, Mason WS.

Gut. 2013 Aug;62(8):1093-5. doi: 10.1136/gutjnl-2013-304594. Epub 2013 Mar 29. Review. No abstract available.

PMID:
23542357
14.

Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.

Cai D, Mills C, Yu W, Yan R, Aldrich CE, Saputelli JR, Mason WS, Xu X, Guo JT, Block TM, Cuconati A, Guo H.

Antimicrob Agents Chemother. 2012 Aug;56(8):4277-88. doi: 10.1128/AAC.00473-12. Epub 2012 May 29.

15.

Reasons to consider earlier treatment of chronic HBV infections.

Zoulim F, Mason WS.

Gut. 2012 Mar;61(3):333-6. doi: 10.1136/gutjnl-2011-300937. Epub 2011 Dec 6. No abstract available.

PMID:
22147510
16.

The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.

Reaiche GY, Le Mire MF, Mason WS, Jilbert AR.

Virology. 2010 Oct 25;406(2):286-92. doi: 10.1016/j.virol.2010.07.013. Epub 2010 Aug 12.

17.

Clonal expansion of normal-appearing human hepatocytes during chronic hepatitis B virus infection.

Mason WS, Liu C, Aldrich CE, Litwin S, Yeh MM.

J Virol. 2010 Aug;84(16):8308-15. doi: 10.1128/JVI.00833-10. Epub 2010 Jun 2.

18.

Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection.

Mason WS, Low HC, Xu C, Aldrich CE, Scougall CA, Grosse A, Clouston A, Chavez D, Litwin S, Peri S, Jilbert AR, Lanford RE.

J Virol. 2009 Sep;83(17):8396-408. doi: 10.1128/JVI.00700-09. Epub 2009 Jun 17.

19.

The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir.

Mason WS, Xu C, Low HC, Saputelli J, Aldrich CE, Scougall C, Grosse A, Colonno R, Litwin S, Jilbert AR.

J Virol. 2009 Feb;83(4):1778-89. doi: 10.1128/JVI.01587-08. Epub 2008 Dec 10.

20.

Immune selection during chronic hepadnavirus infection.

Mason WS, Litwin S, Jilbert AR.

Hepatol Int. 2008 Mar;2(1):3-16. doi: 10.1007/s12072-007-9024-3. Epub 2007 Dec 14.

21.

Hepatocyte turnover in transient and chronic hepadnavirus infections.

Mason WS, Litwin S, Xu C, Jilbert AR.

J Viral Hepat. 2007 Nov;14 Suppl 1:22-8. Review.

PMID:
17958639
22.

miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, Zaret KS, Taylor JM.

RNA Biol. 2004 Jul;1(2):106-13. Epub 2004 Jul 1.

PMID:
17179747
23.

The liver of woodchucks chronically infected with the woodchuck hepatitis virus contains foci of virus core antigen-negative hepatocytes with both altered and normal morphology.

Xu C, Yamamoto T, Zhou T, Aldrich CE, Frank K, Cullen JM, Jilbert AR, Mason WS.

Virology. 2007 Mar 15;359(2):283-94. Epub 2006 Oct 31.

24.

The insertion domain of the duck hepatitis B virus core protein plays a role in nucleocapsid assembly.

Guo H, Aldrich CE, Saputelli J, Xu C, Mason WS.

Virology. 2006 Sep 30;353(2):443-50. Epub 2006 Jul 11.

25.
26.

Cellular and virological mechanisms of HBV drug resistance.

Locarnini S, Mason WS.

J Hepatol. 2006 Feb;44(2):422-31. Epub 2005 Dec 7. Review. No abstract available.

PMID:
16364492
27.

Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivity.

Guo H, Mason WS, Aldrich CE, Saputelli JR, Miller DS, Jilbert AR, Newbold JE.

J Virol. 2005 Mar;79(5):2729-42.

28.

Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection.

Mason WS, Jilbert AR, Summers J.

Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1139-44. Epub 2005 Jan 18.

29.

Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus.

Zhu Y, Cullen JM, Aldrich CE, Saputelli J, Miller D, Seeger C, Mason WS, Jilbert AR.

Virology. 2004 Sep 15;327(1):26-40.

30.

Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy.

Summers J, Mason WS.

Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):638-40. Epub 2003 Dec 29.

31.

Hepatocyte turnover during resolution of a transient hepadnaviral infection.

Summers J, Jilbert AR, Yang W, Aldrich CE, Saputelli J, Litwin S, Toll E, Mason WS.

Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11652-9. Epub 2003 Sep 19.

32.
33.
34.

Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.

Zhu Y, Yamamoto T, Cullen J, Saputelli J, Aldrich CE, Miller DS, Litwin S, Furman PA, Jilbert AR, Mason WS.

J Virol. 2001 Jan;75(1):311-22.

35.

Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.

Zhou T, Guo JT, Nunes FA, Molnar-Kimber KL, Wilson JM, Aldrich CE, Saputelli J, Litwin S, Condreay LD, Seeger C, Mason WS.

J Virol. 2000 Dec;74(24):11754-63.

36.

Hepatitis B virus biology.

Seeger C, Mason WS.

Microbiol Mol Biol Rev. 2000 Mar;64(1):51-68. Review.

37.

Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections.

Guo JT, Zhou H, Liu C, Aldrich C, Saputelli J, Whitaker T, Barrasa MI, Mason WS, Seeger C.

J Virol. 2000 Feb;74(3):1495-505.

38.

Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine.

Zhou T, Saputelli J, Aldrich CE, Deslauriers M, Condreay LD, Mason WS.

Antimicrob Agents Chemother. 1999 Aug;43(8):1947-54.

39.

The state of the state's health. A report from the Oklahoma State Board of Health.

Smith RB, Carmichael JB, Gregory JA, Deckert GH, Diacon GE Jr, Evans HL Jr, Fieker DH, Graves RL, Mason WS 3rd.

J Okla State Med Assoc. 1998 Sep;91(6):362-4. No abstract available.

PMID:
9763771
40.

Aberrant expression of a cytokeratin in a subset of hepatocytes during chronic WHV infection.

Pugh JC, Guo JT, Aldrich C, Rall G, Kajino K, Tennant B, England JM, Mason WS.

Virology. 1998 Sep 15;249(1):68-79.

41.

Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma.

Evans AA, O'Connell AP, Pugh JC, Mason WS, Shen FM, Chen GC, Lin WY, Dia A, M'Boup S, Dramé B, London WT.

Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):559-65.

42.

Lamivudine therapy of WHV-infected woodchucks.

Mason WS, Cullen J, Moraleda G, Saputelli J, Aldrich CE, Miller DS, Tennant B, Frick L, Averett D, Condreay LD, Jilbert AR.

Virology. 1998 May 25;245(1):18-32.

43.
44.

Cloning and expression of a cDNA encoding the large subunit of duck replication factor C.

Guo JT, Liu C, Mason WS, Pugh JC.

Biochim Biophys Acta. 1998 Feb 11;1395(3):293-300.

PMID:
9512663
45.

Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus.

Moraleda G, Saputelli J, Aldrich CE, Averett D, Condreay L, Mason WS.

J Virol. 1997 Dec;71(12):9392-9.

46.

Major differences between WHV and HBV in the regulation of transcription.

Di Q, Summers J, Burch JB, Mason WS.

Virology. 1997 Mar 3;229(1):25-35.

47.

Characterization of serum amyloid A protein mRNA expression and secondary amyloidosis in the domestic duck.

Guo JT, Aldrich CE, Mason WS, Pugh JC.

Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14548-53.

50.

Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.

Fourel I, Cullen JM, Saputelli J, Aldrich CE, Schaffer P, Averett DR, Pugh J, Mason WS.

J Virol. 1994 Dec;68(12):8321-30.

Supplemental Content

Loading ...
Support Center